Top

Published in:

01-05-2010

Echocardiographic Evaluation of Cardiac Amyloid

Authors: Wendy Tsang, Roberto M. Lang

Published in: Current Cardiology Reports | Issue 3/2010

Abstract

Cardiac involvement in amyloidosis has poor prognosis and its diagnosis is challenging because of its patchy, infiltrative nature. Echocardiography plays an important role in the diagnosis, management, and prognosis in this disease process. In this article, we briefly review the utility and problems associated with traditional echocardiographic techniques and discuss the role for new echocardiographic imaging modalities such as tissue Doppler, Doppler-based strain, speckle tracking imaging, and three-dimensional imaging in the assessment of cardiac amyloid.

Dubrey SW, Cha K, Skinner M, et al.: Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart 1997, 78:74–82.PubMed

Falk RH, Plehn JF, Deering T, et al.: Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 1987, 59:418–422.CrossRefPubMed

Palka P, Lange A, Donnelly JE, et al.: Doppler tissue echocardiographic features of cardiac amyloidosis. J Am Soc Echocardiogr 2002, 15:1353–1360.CrossRefPubMed

Cueto-Garcia L, Reeder GS, Kyle RA, et al.: Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985, 6:737–743.PubMed

• Rapezzi C, Merlini G, Quarta CC, et al.: Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009, 120:1203–1212. This is the first study to demonstrate that the echocardiographic findings and clinical course of cardiac amyloid patients are not all the same. AL amyloid, senile amyloid, and hereditary amyloid each cause a different clinical course that is important to realize for management.CrossRefPubMed

• Feng D, Syed IS, Martinez M, et al.: Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation 2009, 119:2490–2497. This paper reports results from an initial autopsy study that revealed a high prevalence of intracardiac thrombi in cardiac amyloid patients. It is the first paper to demonstrate the clinical and echocardiographic findings that should lead clinicians to consider evaluating cardiac amyloid patients for intracardiac thrombus.CrossRefPubMed

Klein AL, Hatle LK, Burstow DJ, et al.: Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1989, 13:1017–1026.PubMedCrossRef

Nihoyannopoulos P, Dawson D: Restrictive cardiomyopathies. Eur J Echocardiogr 2009,10:iii23–iii33.CrossRefPubMed

Brenner DA, Jain M, Pimentel DR, et al.: Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 2004, 94:1008–1010.CrossRefPubMed

10.

Sallach JA, Klein AL: Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis. Curr Opin Cardiol 2004,19:464–471.CrossRefPubMed

11.

Tei C, Dujardin KS, Hodge DO, et al.: Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996, 28:658–664.CrossRefPubMed

12.

Koyama J, Ray-Sequin PA, Davidoff R, Falk RH: Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 2002, 89:1067–1071.CrossRefPubMed

13.

Klein AL, Hatle LK, Taliercio CP, et al.: Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 1991, 83:808–816.PubMed

14.

Patel AR, Dubrey SW, Mendes LA, et al.: Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol 1997, 80:486–492.CrossRefPubMed

15.

Kristen AV, Perz JB, Schonland SO, et al.: Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail 2007, 9:617–624.CrossRefPubMed

16.

•• Austin BA, Duffy B, Tan C, et al.: Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis. Am J Cardiol 2009, 103:1429–1433. This is a interesting paper that examined only endomyocardial biopsy–documented cardiac amyloid and showed that long-term survival is only predicted by New York Heart Association functional class rather than electrocardiographic or echocardiographic variables.CrossRefPubMed

17.

Oki T, Tanaka H, Yamada H, et al.: Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall. Am J Cardiol 2004, 3:864–869.CrossRef

18.

Smiseth OA, Ihlen H: Strain rate imaging: why do we need it? J Am Coll Cardiol 2003, 42:1584–1586.CrossRefPubMed

19.

Koyama J, Ray-Sequin PA, Falk RH: Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 2003, 107:2446–2452.CrossRefPubMed

20.

Bellavia D, Abraham TP, Pellikka PA, et al.: Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr 2007, 20:1194–1202.CrossRefPubMed

21.

Bellavia D, Pellikka PA, Abraham TP, et al.: Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol 2008, 101:1039–1045.CrossRefPubMed

22.

Lindqvist P, Olofsson BO, Backman C, et al.: Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy. Eur J Echocardiogr 2006, 7:22–30.CrossRefPubMed

23.

Al-Zahrani GB, Bellavia D, Pellikka PA, et al.: Doppler myocardial imaging compared to standard two-dimensional and Doppler echocardiography for assessment of diastolic function in patients with systemic amyloidosis. J Am Soc Echocardiogr 2009, 22:290–298.CrossRefPubMed

24.

•• Sun JP, Stewart WJ, Yang XS, et al.: Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol 2009, 103:411–415. This is an interesting paper using 2D SRI in the diagnosis of cardiac amyloidosis from other causes.CrossRefPubMed

25.

Migrino RQ, Harmann L, Woods T, et al.: Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiography. Cardiovasc Ultrasound 2008, 6:40.CrossRefPubMed

26.

Shah KB, Inoue Y, Mehra MR: Amyloidosis and the heart: a comprehensive review. Arch Intern Med 2006, 166:1805–1813.CrossRefPubMed

27.

Abdelmoneim SS, Bernier M, Bellavia D, et al.: Myocardial contrast echocardiography in biopsy-proven primary cardiac amyloidosis. Eur J Echocardiogr 2008, 9:338–341.CrossRefPubMed

28.

Nesbitt GC, Mankad S, Oh JK: Strain imaging in echocardiography: methods and clinical applications. Int J Cardiovasc Imaging 2009, 25(Suppl 1):9–22.CrossRefPubMed

Title: Echocardiographic Evaluation of Cardiac Amyloid
Authors: Wendy Tsang
Roberto M. Lang
Publication date: 01-05-2010
Publisher: Current Science Inc.
Published in: Current Cardiology Reports / Issue 3/2010
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-010-0108-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Echocardiographic Evaluation of Cardiac Amyloid

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2010

Does Irbesartan Improve the Risk of Death or Hospitalization for Cardiovascular Causes Among Patients With HF and PEF?

Contrast Echocardiography: What Have We Learned From the New Guidelines?

Left Ventricular Assist Devices and Other Devices for End-Stage Heart Failure: Utility of Echocardiography

Cardiac Disease in Pregnancy: Value of Echocardiography

Three-Dimensional Echocardiography and Mitral Valve Disease

Cardiac Rehabilitation in Heart Failure: A Brief Review and Recommendations